Filing Details

Accession Number:
0001567619-22-000568
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 16:47:05
Reporting Period:
2022-01-03
Accepted Time:
2022-01-05 16:47:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604464 Atara Biotherapeutics Inc. ATRA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553335 Jakob Dupont C/O Atara Biotherapeutics, Inc.
611 Gateway Boulevard, Suite 900
South San Francisco CA 94080
Evp, Head Of R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-03 5,000 $9.58 95,594 No 4 M Direct
Common Stock Disposition 2022-01-03 5,000 $16.01 90,594 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2022-01-03 5,000 $0.00 5,000 $9.58
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
262,500 2030-05-13 No 4 M Direct
Footnotes
  1. Transaction pursuant to Rule 10b5-1 Plan adopted September 3, 2021.
  2. 25% of the shares subject to the option vested on May 14, 2021 and the remaining shares vest in equal monthly installments over the following 36 months, subject to the reporting person's continuous service.